Metraipolis › archive › dc_a46832e36d2e
Retromer-targeted therapy for neurodegenerative diseases — Europe PMC PMID:42723096
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42723096
- DOI
- 10.1186/s13024-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T19:44:27.848Z
- SHA-256 of the archived text
51a464f0e26d1e51aa24cd37c50bc118465b14a5676f8caa66c26972d8ae3f2f- Stable URL of this page
https://metraipolis.com/documento/dc_a46832e36d2e
How to cite
Retromer-targeted therapy for neurodegenerative diseases — Europe PMC PMID:42723096 — Europe PMC (en), https://europepmc.org/article/MED/42723096 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a46832e36d2e (Metraipolis archive dc_a46832e36d2e, sha256 51a464f0e26d1e51aa24cd37c50bc118465b14a5676f8caa66c26972d8ae3f2f)
BibTeX
@misc{dca46832e36d2e,
title = {Retromer-targeted therapy for neurodegenerative diseases — Europe PMC PMID:42723096},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42723096},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a46832e36d2e; sha256 51a464f0e26d1e51aa24cd37c50bc118465b14a5676f8caa66c26972d8ae3f2f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42723096. Agents can read the archived copy with the MCP tool read_document.